Vasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activity
dc.contributor.author | Ercal, N. | en_US |
dc.contributor.author | O'Dorisio, M. S. | en_US |
dc.contributor.author | Vinik, Aaron I. | en_US |
dc.contributor.author | O'Dorisio, T. M. | en_US |
dc.contributor.author | Kadrofske, Mark M. | en_US |
dc.date.accessioned | 2010-06-01T19:58:02Z | |
dc.date.available | 2010-06-01T19:58:02Z | |
dc.date.issued | 1988-06 | en_US |
dc.identifier.citation | ERCAL, N.; O'DORISIO, M. S.; VINIK, A.; O'DORISIO, T. M.; KADROFSKE, M. (1988). "Vasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activity." Annals of the New York Academy of Sciences 527(1 Vasoactive Intestinal Peptide and Related Peptides ): 663-666. <http://hdl.handle.net/2027.42/73096> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73096 | |
dc.format.extent | 161913 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1988 The New York Academy of Sciences | en_US |
dc.title | Vasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activity | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Physiology, Pediatrics, and Medicine The Ohio State University Columbus, Ohio 43210 and Department of Medicine University of Michigan Ann Arbor, Michigan | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73096/1/j.1749-6632.1988.tb27036.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1988.tb27036.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Cox, C. P., J. Linden & S. I. Said. 1984. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). Peptides 5: 325 – 328. | en_US |
dc.identifier.citedreference | Baenziger, N. L. & P. W. Majerus. 1974. Isolation of human platelets and platelet surface membranes. Methods Enzymol. 31: 149. | en_US |
dc.identifier.citedreference | O'Dorisio, M. S., T. M. O'Dorisio, C. L. Wood, J. C. Bresnahan, M. S. Beattie & L. B. Campolito. 1988. Characterization of vasoactive intestinal peptide receptors in nervous and immune systems. Ann. N.Y. Acad. Sci. This volume. | en_US |
dc.identifier.citedreference | Akera, T. & V. J. K. Cheng. 1977. A simple method for the determination of affinity and binding site concentration in receptor binding studies. Biochem. Biophys. Acta 470: 412 – 423. | en_US |
dc.identifier.citedreference | Farr, R. S., C. P. Cox, M. L. Wordlow & R. Jorgensen. 1980. Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin. Immunol. Immunopathol. 15: 318 – 330. | en_US |
dc.identifier.citedreference | Chignard, M., J. P. Le Couedic, M. Tence, B. B. Vargaftig & J. Beneviste. 1979. The role of platelet activating factor in platelet aggregation. Nature (London) 279: 799 – 800. | en_US |
dc.identifier.citedreference | Haslam, R. J. & M. Vanderwell. 1982. Inhibition of platelet adenylate cyclase by 1-0-alkyl-2-0-acetyl-sn-glycerl-3-phosphorylcholine (PAF). J. Biol. Chem. 257: 6879 – 6885. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.